Consensus PDS Biotechnology Corporation

Equities

PDSB

US70465T1079

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
3.27 ^USD	+0.31%		+23.63%	-34.21%

Mar. 28	B. Riley Securities Adjusts PDS Biotechnology's Price Target to $11 From $14, Maintains Buy Rating	MT
Mar. 27	Empire Metals targets key milestones in Australia	AN

Evolution of the average Target Price on PDS Biotechnology Corporation

Price target over the last 5 years

History of analyst recommendation changes

20a95ad6d3778a35b378f1f2.1xPzZWUyIrcpURjY7j8t9sbZ1T2kZgeikDamsf0QGUg.mFyrKRd9TeBxZ3y-l3Ealb67kVXQS034wn3CwZpmbAaVJItIC11Q420-SQ~a11c49512bbe23d80bce92578d87f8ca

Analyst Recommendations on PDS Biotechnology Corporation

B. Riley Securities Adjusts PDS Biotechnology's Price Target to $11 From $14, Maintains Buy Rating	Mar. 28	MT
Oppenheimer Adjusts PDS Biotechnology Price Target to $20 From $23, Maintains Outperform Rating	Nov. 15	MT
Oppenheimer Adjusts PDS Biotechnology Price Target to $23 From $24, Maintains Outperform Rating	23-08-15	MT
PDS Biotechnology Corporation Announces Interim Data Demonstrates 12-Month Survival Rate of 87% with PDS0101 in Combination with Keytruda (Pembrolizumab) for Head and Neck Cancer Patients	23-05-25	CI
HC Wainwright Adjusts Price Target on PDS Biotechnology to $21 From $15, Maintains Buy Rating	23-01-03	MT
B. Riley Lifts Price Target on PDS Biotechnology to $12 From $10, Cites Higher Probability of Success for Triplet Regimen; Buy Kept	22-12-29	MT
Chardan Increases Price Target on PDS Biotechnology to $16 From $15, Keeps Buy Rating	22-11-15	MT
B. Riley Securities Starts PDS Biotechnology at Buy With $10 Price Target	22-11-01	MT
Alliance Global Adjusts Price Target on PDS Biotechnology to $16 From $18, Reiterates Buy Rating	22-05-16	MT
PDS BIOTECHNOLOGY : HC Wainwright Adjusts Price Target on PDS Biotechnology to $15 From $20, Maintains Buy Rating	21-08-12	MT
PDS BIOTECHNOLOGY : Cantor Fitzgerald Starts PDS Biotechnology at Overweight With $25 Price Target	21-06-28	MT
PDS BIOTECHNOLOGY : Alliance Global Partners Adjusts Price Target on PDS Biotechnology to $18 From $6.50, Maintains Buy Rating	21-06-09	MT
PDS BIOTECHNOLOGY : Chardan Adjusts Price Target on PDS Biotechnology to $15 From $11, Maintains Buy Rating	21-06-09	MT
PDS BIOTECHNOLOGY : Oppenheimer Adjusts PDS Biotechnology's Price Target to $25 From $12, Maintains Outperform Rating	21-06-09	MT
PDS BIOTECHNOLOGY : HC Wainwright Adjusts PDS Biotechnology's PT to $20 from $8, Keeps Buy Rating	21-06-02	MT
PDS BIOTECHNOLOGY : Chardan Capital Adjusts Price Target on PDS Biotechnology to $11 From $10, Maintains Buy Rating	21-05-20	MT
PDS BIOTECHNOLOGY : Oppenheimer Adjusts PDS Biotechnology PT to $12 From $7, Maintains Outperform Rating	21-03-19	MT
PDS BIOTECHNOLOGY : HC Wainwright Adjusts PDS Biotechnology's Price Target to $8 from $6, Keeps Buy Rating	21-03-19	MT
PDS BIOTECHNOLOGY : Oppenheimer Initiates Coverage on PDS Biotechnology With Outperform Rating, $7 Price Target	20-12-04	MT
PDS BIOTECHNOLOGY : HC Wainwright Upgrades PDS Biotechnology to Buy From Neutral; Price Target is $6	20-11-10	MT